Literature DB >> 15833784

Comparison of the unsaturated iron-binding capacity with transferrin saturation as a screening test to detect C282Y homozygotes for hemochromatosis in 101,168 participants in the hemochromatosis and iron overload screening (HEIRS) study.

Paul C Adams1, David M Reboussin, Cathie Leiendecker-Foster, Godfrey C Moses, Gordon D McLaren, Christine E McLaren, Fitzroy W Dawkins, Ishmael Kasvosve, Ron T Acton, James C Barton, Dan Zaccaro, Emily L Harris, Richard Press, Henry Chang, John H Eckfeldt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15833784     DOI： 10.1373/clinchem.2005.048371

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  12 in total

1.  Clinical guidelines: HFE hemochromatosis-screening, diagnosis and management.

Authors:  James C Barton; Paul C Adams
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-09       Impact factor: 46.802

Review 2.  A diagnostic approach to hemochromatosis.

Authors:  Anthony S Tavill; Paul C Adams
Journal:  Can J Gastroenterol       Date:  2006-08       Impact factor: 3.522

3.  Predicting C282Y homozygote genotype for hemochromatosis using serum ferritin and transferrin saturation values from 44,809 participants of the HEIRS study.

Authors:  Andrew Lim; Mark Speechley; Paul C Adams
Journal:  Can J Gastroenterol Hepatol       Date:  2014-10

4.  Normal iron metabolism and the pathophysiology of iron overload disorders.

Authors:  Chiang W Siah; John Ombiga; Leon A Adams; Debbie Trinder; John K Olynyk
Journal:  Clin Biochem Rev       Date:  2006-02

5.  Probability of C282Y homozygosity decreases as liver transaminase activities increase in participants with hyperferritinemia in the hemochromatosis and iron overload screening study.

Authors:  Paul C Adams; Mark Speechley; James C Barton; Christine E McLaren; Gordon D McLaren; John H Eckfeldt
Journal:  Hepatology       Date:  2012-04-18       Impact factor: 17.425

6.  Serum ferritin, insulin resistance, and metabolic syndrome: clinical and laboratory associations in 769 non-hispanic whites without diabetes mellitus in the HEIRS study.

Authors:  Ronald T Acton; J Clayborn Barton; James C Barton
Journal:  Metab Syndr Relat Disord       Date:  2014-11-25       Impact factor: 1.894

7.  Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) Study.

Authors:  Gordon D McLaren; Victor R Gordeuk
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009

8.  Biological variability of transferrin saturation and unsaturated iron-binding capacity.

Authors:  Paul C Adams; David M Reboussin; Richard D Press; James C Barton; Ronald T Acton; Godfrey C Moses; Catherine Leiendecker-Foster; Gordon D McLaren; Fitzroy W Dawkins; Victor R Gordeuk; Laura Lovato; John H Eckfeldt
Journal:  Am J Med       Date:  2007-11       Impact factor: 4.965

9.  Clinical manifestations of hemochromatosis in HFE C282Y homozygotes identified by screening.

Authors:  Gordon D McLaren; Christine E McLaren; Paul C Adams; James C Barton; David M Reboussin; Victor R Gordeuk; Ronald T Acton; Emily L Harris; Mark R Speechley; Phyliss Sholinsky; Fitzroy W Dawkins; Beverly M Snively; Thomas M Vogt; John H Eckfeldt
Journal:  Can J Gastroenterol       Date:  2008-11       Impact factor: 3.522

10.  Impact of gene patents and licensing practices on access to genetic testing for hereditary hemochromatosis.

Authors:  Subhashini Chandrasekharan; Emily Pitlick; Christopher Heaney; Robert Cook-Deegan
Journal:  Genet Med       Date:  2010-04       Impact factor: 8.822
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.